Envista Holdings Corporation Common stock, $0.01 par value per share insider trading
NVSTfinancial statementsForm 4 filings on EDGAR62 transactions since Nov 16, 2024
From August 19, 2026 to November 16, 2026, 0 insiders at Envista Holdings Corporation Common stock, $0.01 par value per share bought $0 of stock in the open market, and 1 sold $220K. Officers and directors accounted for $0 of purchases and $220K of sales. The last reported transaction was a tax withholding by Keel Paul A on November 1, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through November 2, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $220KAug 19, 2026 – Nov 16, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Nov 13, 2026. Insider data through Nov 16, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
62 transactions from November 16, 2024 to November 16, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2026 | Keel Paul A | Chairman and CEO, Director | tax withholding | 54,197 | $23.51 | $1M | 497,107 | Nov 2, 2026 |
| Aug 25, 2026 | Acurio Veronica | President, Orthodontics | tax withholding | 7,710 | $27.47 | $212K | 48,806 | Aug 27, 2026 |
| Aug 25, 2026 | Befidi Robert | President, Diagnostics | tax withholding | 5,147 | $27.47 | $141K | 45,785 | Aug 27, 2026 |
| Aug 25, 2026 | Hammes Eric D. | Chief Financial Officer | tax withholding | 10,885 | $27.47 | $299K | 99,913 | Aug 27, 2026 |
| Aug 25, 2026 | Nilsson Stefan | President, Nobel Biocare | tax withholding | 804 | $27.47 | $22K | 61,560 | Aug 27, 2026 |
| Aug 20, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | open-market sale10b5-1 | 8,000 | $27.50 | $220K | 27,321 | Aug 24, 2026 |
| Aug 18, 2026 | Keel Paul A | Chief Executive Officer, Director | award | 179,730 | $0.00 | — | 551,304 | Aug 20, 2026 |
| May 25, 2026 | Keel Paul A | Chief Executive Officer, Director | tax withholding | 12,811 | $23.43 | $300K | 371,574 | May 27, 2026 |
| May 19, 2026 | Carruthers Wendy | Director | award | 9,330 | $0.00 | — | 59,940 | May 21, 2026 |
| May 19, 2026 | Tsingos Christine A | Director | award | 9,330 | $0.00 | — | 59,930 | May 21, 2026 |
| May 19, 2026 | Jain Vivek | Director | award | 9,330 | $0.00 | — | 52,945 | May 21, 2026 |
| May 19, 2026 | Gallahue Kieran | Director | award | 9,330 | $0.00 | — | 54,010 | May 21, 2026 |
| May 19, 2026 | Pierce James Andrew | Director | award | 9,330 | $0.00 | — | 18,485 | May 21, 2026 |
| May 19, 2026 | Raskas Daniel | Director | award | 9,330 | $0.00 | — | 54,010 | May 21, 2026 |
| May 19, 2026 | Huennekens R Scott | Director | award | 12,585 | $0.00 | — | 82,105 | May 21, 2026 |
| Feb 25, 2026 | Hammes Eric D. | Chief Financial Officer | tax withholding | 2,045 | $29.59 | $61K | 94,743 | Feb 27, 2026 |
| Feb 25, 2026 | Hammes Eric D. | Chief Financial Officer | award | 16,055 | $0.00 | — | 110,798 | Feb 27, 2026 |
| Feb 25, 2026 | Acurio Veronica | President, Orthodontics | tax withholding | 1,412 | $29.59 | $42K | 48,911 | Feb 27, 2026 |
| Feb 25, 2026 | Acurio Veronica | President, Orthodontics | award | 7,605 | $0.00 | — | 56,516 | Feb 27, 2026 |
| Feb 25, 2026 | Nilsson Stefan | President, Nobel Biocare | tax withholding | 182 | $29.59 | $5K | 54,759 | Feb 27, 2026 |
| Feb 25, 2026 | Nilsson Stefan | President, Nobel Biocare | award | 7,605 | $0.00 | — | 62,364 | Feb 27, 2026 |
| Feb 25, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | tax withholding | 2,976 | $29.59 | $88K | 29,406 | Feb 27, 2026 |
| Feb 25, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | award | 5,915 | $0.00 | — | 35,321 | Feb 27, 2026 |
| Feb 25, 2026 | Nance Mark E | General Counsel | award | 12,675 | $0.00 | — | 81,252 | Feb 27, 2026 |
| Feb 25, 2026 | Nance Mark E | General Counsel | tax withholding | 3,368 | $29.59 | $100K | 68,577 | Feb 27, 2026 |
| Feb 25, 2026 | Kaabi Faez C | Chief Accounting Officer | tax withholding | 4,964 | $29.59 | $147K | 45,032 | Feb 27, 2026 |
| Feb 25, 2026 | Kaabi Faez C | Chief Accounting Officer | award | 13,520 | $0.00 | — | 58,552 | Feb 27, 2026 |
| Feb 25, 2026 | Keel Paul A | Chief Executive Officer, Director | award | 48,670 | $0.00 | — | 384,385 | Feb 27, 2026 |
| Feb 25, 2026 | Keel Paul A | Chief Executive Officer, Director | tax withholding | 11,840 | $29.59 | $350K | 335,715 | Feb 27, 2026 |
| Feb 25, 2026 | Befidi Robert | President, Diagnostics | tax withholding | 2,177 | $29.59 | $64K | 43,327 | Feb 27, 2026 |
| Feb 25, 2026 | Befidi Robert | President, Diagnostics | award | 7,605 | $0.00 | — | 50,932 | Feb 27, 2026 |
| Feb 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | open-market sale10b5-1 | 5,634 | $30.00 | $169K | 32,382 | Feb 11, 2026 |
| Feb 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | open-market sale10b5-1 | 4,041 | $30.00 | $121K | 32,382 | Feb 11, 2026 |
| Feb 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | option exercise | 4,041 | $19.04 | $77K | 36,423 | Feb 11, 2026 |
| Feb 10, 2026 | Reis Mischa | SVP, Strategy & Bus. Dev. | option exercise | 5,634 | $15.97 | $90K | 38,016 | Feb 11, 2026 |
| Nov 1, 2025 | Keel Paul A | Chief Executive Officer, Director | tax withholding | 54,097 | $20.35 | $1M | 347,555 | Nov 4, 2025 |
| Aug 25, 2025 | Befidi Robert | President, Diagnostics | tax withholding | 3,454 | $21.12 | $73K | 45,504 | Aug 27, 2025 |
| Aug 25, 2025 | Hammes Eric D. | Chief Financial Officer | tax withholding | 7,654 | $21.12 | $162K | 96,788 | Aug 27, 2025 |
| Aug 25, 2025 | Nilsson Stefan | President, Nobel Biocare | tax withholding | 804 | $21.12 | $17K | 54,941 | Aug 27, 2025 |
| Aug 25, 2025 | Acurio Veronica | President, Orthodontics | tax withholding | 5,422 | $21.12 | $115K | 50,323 | Aug 27, 2025 |
| Aug 25, 2025 | Reis Mischa | SVP, Strategy & Bus. Dev. | open-market sale10b5-1 | 15,000 | $21.60 | $324K | 32,382 | Aug 27, 2025 |
| Jul 14, 2025 | Pierce James Andrew | Director | award | 9,155 | $0.00 | — | 9,155 | Jul 16, 2025 |
| Jun 10, 2025 | Gallahue Kieran | Director | award | 10,450 | $0.00 | — | 44,680 | Jun 12, 2025 |
| Jun 10, 2025 | Raskas Daniel | Director | award | 10,450 | $0.00 | — | 44,680 | Jun 12, 2025 |
| Jun 10, 2025 | Jain Vivek | Director | award | 10,450 | $0.00 | — | 43,615 | Jun 12, 2025 |
| Jun 10, 2025 | Carruthers Wendy | Director | award | 10,450 | $0.00 | — | 50,610 | Jun 12, 2025 |
| Jun 10, 2025 | Tsingos Christine A | Director | award | 10,450 | $0.00 | — | 50,600 | Jun 12, 2025 |
| Jun 10, 2025 | Hulit Barbara B. | Director | award | 10,450 | $0.00 | — | 79,820 | Jun 12, 2025 |
| Jun 10, 2025 | Huennekens R Scott | Director | award | 14,370 | $0.00 | — | 69,520 | Jun 12, 2025 |
| May 25, 2025 | Keel Paul A | Chief Executive Officer, Director | tax withholding | 12,787 | $16.72 | $214K | 401,652 | May 27, 2025 |
Who the insiders are
Everyone who reported a transaction since November 16, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Reis Mischa | SVP, Strategy & Bus. Dev. | Aug 20, 2026 | open-market sale | 27,321 | — | $510K (3) | 3 of 3 |
| Keel Paul A | Chairman and CEO, Director | Nov 1, 2026 | tax withholding | 497,107 | — | — | — |
| Befidi Robert | President, Diagnostics | Aug 25, 2026 | tax withholding | 45,785 | — | — | — |
| Acurio Veronica | President, Orthodontics | Aug 25, 2026 | tax withholding | 48,806 | — | — | — |
| Hammes Eric D. | Chief Financial Officer | Aug 25, 2026 | tax withholding | 99,913 | — | — | — |
| Nilsson Stefan | President, Nobel Biocare | Aug 25, 2026 | tax withholding | 61,560 | — | — | — |
| Nance Mark E | General Counsel | Feb 25, 2026 | award | 81,252 | — | — | — |
| Kaabi Faez C | Chief Accounting Officer | Feb 25, 2026 | tax withholding | 45,032 | — | — | — |
| Carruthers Wendy | Director | May 19, 2026 | award | 59,940 | — | — | — |
| Tsingos Christine A | Director | May 19, 2026 | award | 59,930 | — | — | — |
| Jain Vivek | Director | May 19, 2026 | award | 52,945 | — | — | — |
| Gallahue Kieran | Director | May 19, 2026 | award | 54,010 | — | — | — |
| Pierce James Andrew | Director | May 19, 2026 | award | 18,485 | — | — | — |
| Raskas Daniel | Director | May 19, 2026 | award | 54,010 | — | — | — |
| Huennekens R Scott | Director | May 19, 2026 | award | 82,105 | — | — | — |
| Hulit Barbara B. | Director | Jun 10, 2025 | award | 79,820 | — | — | — |
Questions
Are Envista Holdings Corporation Common stock, $0.01 par value per share insiders buying or selling?
Over the twelve months to November 16, 2026, 1 insider at Envista Holdings Corporation Common stock, $0.01 par value per share sold $510K of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $510K. Only open-market purchases and sales are counted.
Who sold the most Envista Holdings Corporation Common stock, $0.01 par value per share stock in the last year?
Reis Mischa (SVP, Strategy & Bus. Dev.) sold $510K in 3 open-market sales over the twelve months to November 16, 2026.
Do Envista Holdings Corporation Common stock, $0.01 par value per share executives sell under 10b5-1 plans?
3 of the 3 open-market sales in the last twelve months (100%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Envista Holdings Corporation Common stock, $0.01 par value per share
- Envista Holdings Corporation Common stock, $0.01 par value per share financial statements
- 1 tracked fund holding NVST
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.